New research suggests that the immunotoxicity of chemotherapy in lipid nanoparticles (LNPs) can be mitigated through chemical conjugation, potentially improving the safety and efficacy of these therapeutic agents. According to a recent…
New research suggests that the immunotoxicity of chemotherapy in lipid nanoparticles (LNPs) can be mitigated through chemical conjugation, potentially improving the safety and efficacy of these therapeutic agents. According to a recent…